Physician profile
Anton Camaj
NPI 1417489089
$76,352.49
in general payments reported to CMS, 2019-2025
28 companies · $7,110 in 2025
The $7,110 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $452 · 2021: $1,262 · 2022: $666 · 2023: $19K · 2024: $48K · 2025: $7,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $57K · Food and Beverage: $15K · Travel and Lodging: $2,149 · Consulting Fee: $200 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $57,000.00 |
| Food and Beverage | $14,622.23 |
| Travel and Lodging | $2,149.25 |
| Consulting Fee | $200.00 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $44,436.08 | 2023-2025 | Mitraclip, Amplatzer Amulet, Navitor |
| Medtronic, INC. | $17,373.63 | 2023-2025 | Corevalve Evolut R, Abre, Symplicity G3 |
| Edwards Lifesciences Corporation | $3,858.80 | 2023-2025 | Sapien 3 Ultra Resilia, Evoque |
| Shockwave Medical, INC | $2,153.83 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $1,650.39 | 2020-2025 | Farxiga, Andexxa, Lokelma |
| Boston Scientific Corporation | $745.46 | 2021-2025 | Avvigo Guidance System, Watchman Flx, Mach1 |
| Cardiovascular Systems INC. | $743.39 | 2020-2021 | |
| Terumo Medical Corporation | $726.04 | 2023-2024 | Glidesheath Slender, Azur Cx Detachable, Metacross Otw |
| W. L. Gore & Associates, INC. | $637.09 | 2025 | Gore Cardioform Septal Occluder |
| Abiomed | $500.70 | 2024 | Impella |
| Chiesi USA, INC. | $444.49 | 2023-2024 | Kengreal |
| Philips North America LLC | $370.03 | 2022-2025 | Igt Devices Undivided, Ice 3d, (Az7) Lasers |
| Amgen INC. | $362.33 | 2022-2024 | Repatha |
| Cardiva Medical, INC. | $355.42 | 2023 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Heartflow, INC. | $312.80 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $303.34 | 2024 | Lutonix Drug Coated Balloon, Crosser Iq, Ultraverse 014 |
| Biotronik INC. | $227.00 | 2023-2024 | Orsiro Mission, Nhancer Rx |
| Elucid Bioimaging INC | $200.00 | 2025 | Plaqueiq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.31 | 2021-2024 | Lifevest |
| Lantheus Medical Imaging, INC. | $161.28 | 2020-2022 | |
| Pfizer INC. | $150.58 | 2023-2024 | |
| Stryker Corporation | $126.60 | 2025 | Flowtriever |
| Novartis Pharmaceuticals Corporation | $112.50 | 2024-2025 | |
| Inari Medical, INC. | $104.33 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $50.52 | 2020-2023 | Camzyos |
| Alnylam Pharmaceuticals INC. | $28.16 | 2025 | Amvuttra |
| Limflow INC. | $26.89 | 2023 | Limflow System |
| Bayer Healthcare Pharmaceuticals INC. | $23.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Camaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.